Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Hawaii Oncology Inc-Pali Momi
mi
from
'Aiea, HI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Hawaii Oncology Inc-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Pali Momi Medical Center
mi
from
'Aiea, HI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Reid Health
mi
from
Richmond, IN
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Saint Vincent Frontier Cancer Center
mi
from
Billings, MT
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Saint Vincent Frontier Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Memorial Sloan Kettering Sleepy Hollow
mi
from
Sleepy Hollow, NY
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Memorial Sloan Kettering Sleepy Hollow
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Sanford Broadway Medical Center
mi
from
Fargo, ND
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Wright-Patterson Medical Center
mi
from
Wright-Patterson Air Force Base, OH
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Wright-Patterson Medical Center
mi
from
Wright-Patterson Air Force Base, OH
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
HSHS Saint Nicholas Hospital
mi
from
Sheboygan, WI
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
HSHS Saint Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
MedStar Washington Hospital Center
mi
from
Washington,
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated:  11/29/2017
Central Vermont Medical Center/National Life Cancer Treatment
mi
from
Berlin, VT
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Status: Enrolling
Updated: 11/29/2017
Central Vermont Medical Center/National Life Cancer Treatment
mi
from
Berlin, VT
Click here to add this to my saved trials
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Phase I/II Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  11/29/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Phase I/II Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 11/29/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Pain Management Using Mobile Technology in Veterans With PTSD and TBI
Pain Management Using Mobile Technology in Veterans With PTSD and TBI
Status: Enrolling
Updated:  11/30/2017
Duke University, Department of Psychiatry
mi
from
Durham, NC
Pain Management Using Mobile Technology in Veterans With PTSD and TBI
Pain Management Using Mobile Technology in Veterans With PTSD and TBI
Status: Enrolling
Updated: 11/30/2017
Duke University, Department of Psychiatry
mi
from
Durham, NC
Click here to add this to my saved trials
Stem Cell Transplant for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Stem Cell Transplant for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  12/3/2017
University of Minnesota - Fairview
mi
from
Minneapolis, MN
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 12/3/2017
University of Minnesota - Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
Phase I-II Clinical Trial to Determine the Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
Status: Enrolling
Updated:  12/4/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
Phase I-II Clinical Trial to Determine the Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
Status: Enrolling
Updated: 12/4/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington Medicine MS Center
mi
from
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington Medicine MS Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington, Health Sciences Building
mi
from
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington, Health Sciences Building
mi
from
Seattle, WA
Click here to add this to my saved trials
Postural Control and Fine Motor Skills in People With Stroke
Biomechanical Assessment of the Relationship Between Postural Control and Fine Motor Skills in People With Stroke
Status: Enrolling
Updated:  12/5/2017
Medical University of South Carolina
mi
from
Charleston, SC
Postural Control and Fine Motor Skills in People With Stroke
Biomechanical Assessment of the Relationship Between Postural Control and Fine Motor Skills in People With Stroke
Status: Enrolling
Updated: 12/5/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Usability Testing of Affordable Haptic Robots for Stroke Therapy
Usability Testing of Affordable Haptic Robots for Stroke Therapy
Status: Enrolling
Updated:  12/5/2017
Penn Medicine Rittenhouse
mi
from
Philadelphia, PA
Usability Testing of Affordable Haptic Robots for Stroke Therapy
Usability Testing of Affordable Haptic Robots for Stroke Therapy
Status: Enrolling
Updated: 12/5/2017
Penn Medicine Rittenhouse
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Tolerability and Efficacy of Depakote-extended Release in the Elderly
Tolerability and Efficacy of Depakote-ER in the Elderly
Status: Enrolling
Updated:  12/5/2017
Virginia Commonwealth University Medical Center, Department of Neurology
mi
from
Richmond, VA
Tolerability and Efficacy of Depakote-extended Release in the Elderly
Tolerability and Efficacy of Depakote-ER in the Elderly
Status: Enrolling
Updated: 12/5/2017
Virginia Commonwealth University Medical Center, Department of Neurology
mi
from
Richmond, VA
Click here to add this to my saved trials
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/6/2017
UC Davis Health System
mi
from
Sacramento, CA
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/6/2017
UC Davis Health System
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/6/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/6/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/6/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/6/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/6/2017
Hospital de Pediatria Prof Dr Juan P Garrahan
mi
from
Buenos Aires,
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/6/2017
Hospital de Pediatria Prof Dr Juan P Garrahan
mi
from
Buenos Aires,
Click here to add this to my saved trials
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
UCLA
mi
from
Los Angeles, CA
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Lurie Children's Hospital
mi
from
Chicago, IL
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Rochester
mi
from
Rochester, NY
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Utah
mi
from
Salt Lake City, UT
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study: A Coverage With Evidence Development Longitudinal Cohort Study
Status: Enrolling
Updated:  12/6/2017
American College of Radiology Imaging Network
mi
from
Philadelphia, PA
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study: A Coverage With Evidence Development Longitudinal Cohort Study
Status: Enrolling
Updated: 12/6/2017
American College of Radiology Imaging Network
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study: A Coverage With Evidence Development Longitudinal Cohort Study
Status: Enrolling
Updated:  12/6/2017
Https://Www.Ideas-Study.Org/Site-Locator/
mi
from
Philadelphia, PA
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study: A Coverage With Evidence Development Longitudinal Cohort Study
Status: Enrolling
Updated: 12/6/2017
Https://Www.Ideas-Study.Org/Site-Locator/
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of California-Davis
mi
from
Sacramento, CA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Children'S Hospital
mi
from
Aurora, CO
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Child Neurology Center of Pensacola
mi
from
Pensacola, FL
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Child Neurology Center of Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Iowa Healthcare
mi
from
Iowa City, IA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Iowa Healthcare
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Kansas Medical Centre
mi
from
Kansas City, KA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Kansas Medical Centre
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Children's Hospital Boston - Harvard Medical School
mi
from
Boston, MA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Children's Hospital Boston - Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Columbia University Medical School
mi
from
New York, NY
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Columbia University Medical School
mi
from
New York, NY
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials